Title: A Review of the World's Commercial Pipeline of GM Crops and Implications for Asynchronous Approvals and Trade
Authors: STEIN Alexander JivrajRODRIGUEZ CEREZO Emilio
Citation: XIII. ICABR - International Consortium on Agricultural Biotechnology Research p. 1-10
Publisher: International Consortium on Agricultural Biotechnology Research
Publication Year: 2009
JRC N°: JRC52063
URI: http://www.economia.uniroma2.it/icabr/paper_view.php?id=421&p=5
http://publications.jrc.ec.europa.eu/repository/handle/JRC52063
Type: Contributions to Conferences
Abstract: Commission's Joint Research Centre (JRC), Institute for Prospective Tech¬nological Studies (IPTS). The panel gathered GM technology developers (private and public), regulators and stakeholders involved in the commercialisation of GM crops worldwide. The main objective is to compile a world-wide pipeline of new GM crops that are to being commercialised in the short to medium term. This commercial pipeline of new GM crops will be analysed in view of asynchronous approval of GM crops by the EU and its trading partners that may result in restrictions in access to certain commodity markets (including the possible impacts for the farming sector, commodity traders and the food and feed industry). In this context it is paramount to obtain a clearer overview of new GMOs that are in the global commercial pipeline for relevant crops. Once such an overview has been compiled, this information can be used as input for more detailed economic evaluations to assess and quantify the potential impact of asynchro¬nous approval of GMOs and, thus, to help policy makers understand the scope of the problem and the need for action. While the main emphasis is on market access, the compilation of the pipeline will also serve to discuss the relative position of the EU in the R&D of key agricultural crops.
JRC Institute:Institute for Prospective Technological Studies

Files in This Item:
There are no files associated with this item.


Items in repository are protected by copyright, with all rights reserved, unless otherwise indicated.